Innoventric (Series B)
Funding Details
Awarder
Inbox
Date Award
October 29, 2024
Vertical
Medtech
Funding URL
View Funding Page
Funding Amount
$28,500,000
Company Info
Market
Healthcare
Location
Israel
Company Description

Innoventric is an Israeli company that develops transcatheter Tricuspid Regurgitation (TR) treatment, addressing a condition that impairs cardiac blood flow.

Links
Back to HomeBack to Medtech DealsView Funding Announcement